Session Details

C009 Regenerative Therapies for Hair Loss: Evidence, Safety, and Synergistic Approaches in Clinical Practice

Sun, Mar 21, 1:00 PM - 4:00 PM
3 CME Available Course Additional Fee Required NEW

DESCRIPTION

Regenerative therapies for hair loss are increasingly requested by patients and increasingly offered in aesthetic and dermatology practices, yet the field remains heterogeneous, with wide variation in protocols, terminology, evidence quality, regulatory status, and patient counseling. This course will provide a practical, evidence-aware overview of regenerative approaches for hair loss, including platelet-rich plasma, growth factor–based approaches, secretomes, extracellular vesicles/exosomes, stem cell–derived products, and combination strategies using procedural devices such as microneedling, radiofrequency microneedling, lasers, and photobiomodulation. Faculty will review biologic rationale, current clinical evidence, patient selection, treatment protocols, safety considerations, and regulatory boundaries. Particular emphasis will be placed on distinguishing established or commonly used treatments, such as PRP, from investigational or commercially promoted approaches, such as exosomes and stem cell–derived products, for which FDA has warned that unapproved regenerative products may be marketed without adequate evidence of safety, purity, potency, or efficacy.

LEARNING OBJECTIVES

1.

Differentiate regenerative hair loss therapies by biologic mechanism, evidence base, and regulatory status, including PRP, growth factors, secretomes, extracellular vesicles/exosomes, and stem cell–derived products

2.

Evaluate patient selection, treatment planning, and safety considerations for regenerative approaches in androgenetic alopecia, telogen effluvium, alopecia areata adjunctive care, and post-procedural hair restoration support

3.

Develop evidence-aware combination strategies that integrate regenerative therapies with procedural devices such as microneedling, radiofrequency microneedling, lasers, and photobiomodulation while avoiding unsupported claims

SCHEDULE

1:00 PM

Biological rational and clinical potential of regenerative therapies for hair loss

Neil S. Sadick, MD, FAAD

1:10 PM

Platelet-based therapies for hair loss

Maria K. Hordinsky, MD, FAAD

1:35 PM

Emerging regenerative therapies for hair loss

2:00 PM

Safety and regulatory considerations of regenerative therapies

Ronda S. Farah, MD, FAAD

2:20 PM

Break

2:30 PM

Regenerative properties of energy-based devices

Suleima Arruda, MD, IFAAD

2:50 PM

Case-based treatment planning Selecting candidates, sequencing treatments, and managing expectations

Marc R. Avram, MD, FAAD

3:10 PM

Measuring outcomes and planning follow-up Photography, trichoscopy, response assessment, and maintenance

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

3:30 PM

Panel discussion and Q&A

DIRECTOR

Neil S. Sadick, MD, FAAD

Neil S. Sadick, MD, FAAD

SPEAKERS

Suleima Arruda, MD, IFAAD

Suleima Arruda, MD, IFAAD

Sadick Research Group

Marc R. Avram, MD, FAAD

Marc R. Avram, MD, FAAD

Clinical Professor of Dermatology, Weill Cornell Medical Center/New York Presbyterian Hospital, New York, NY

Ronda S. Farah, MD, FAAD

Ronda S. Farah, MD, FAAD

DISCLOSURES

Suleima Arruda, MD, IFAAD

No financial relationships exist with ineligible companies.

Marc R. Avram, MD, FAAD

L'Oreal – Consultant (1099 relationship)(Honoraria); Lumenis Be Ltd. – Consultant (1099 relationship)(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Rion Aesthetics – Consultant (1099 relationship)(Honoraria);

Ronda S. Farah, MD, FAAD

American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Intrepid Therapeutics, Inc. – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Sun Pharma Advanced Research Company (SPARC) – Advisory Board(Honoraria); Technoderma Medicines – Investigator(Grants/Research Funding); Veradermics – Advisory Board(Honoraria), Investigator(Grants/Research Funding);

Neil S. Sadick, MD, FAAD

AbbVie – Consultant(Fees); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Acorn Biolabs – Speaker(Honoraria); Advalight – Investigator(Grants/Research Funding), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Alma Lasers, Inc. – Investigator(Equipment), Investigator(Grants/Research Funding); American Academy of Dermatology – Speaker(No Compensation Received); American Hair Research Society – Board of Directors(No Compensation Received); American Society of Dermatologic Surgery – Speaker(No Compensation Received); Amgen – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Aurigene Discovery Technologies Ltd – Independent Contractor(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bellus Health – Investigator(Grants/Research Funding); Biorasi, LLC – Investigator(Grants/Research Funding); Biosion – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Other(Equipment); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cell Research Corp – Consultant (1099 relationship)(Honoraria); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Other(Equipment), Speaker(Honoraria); Derm Advance – Stockholder(Stock Options); Derm Tech International – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Distinct Dermatology – Stockholder Private Company(Stock Options); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); EndyMed Medical Inc. USA – Speaker(Honoraria); Fortrea – Investigator(No Compensation Received); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Galderma USA – Investigator(Grants/Research Funding); Gerson Lehrman Group – Consultant(Honoraria); GlaxoSmithKline Immunology – Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); ICON plc. – Investigator(No Compensation Received); IMCAS – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Other Financial Benefit); Incyte Corporation – Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); Innovaderm Research Inc. – Investigator(No Compensation Received); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Kimera Labs, Inc – Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); LCN Consulting – Consultant(Fees); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant(Fees), Investigator(Grants/Research Funding); Lumisque – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Investigator(Grants/Research Funding); Paraxel Therapeutics, Inc – Investigator(No Compensation Received); Pfizer Inc. – Investigator(Grants/Research Funding); PPD Inc. – Investigator(Grants/Research Funding); Rho Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Equipment), Investigator(Grants/Research Funding); Scientus Pharma Inc. – Stockholder(Stock Options); Shaperon – Investigator(Equipment), Investigator(Grants/Research Funding); Syneos Health – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Taylor & Francis – Other(Other Financial Benefit); UCB – Investigator(Equipment), Investigator(Grants/Research Funding); Union Therapeutics – Investigator(Grants/Research Funding); Venus Concept – Investigator(Grants/Research Funding), Other(Equipment), Stockholder(Stock Options); Veradermics – Advisory Board(Fees); VeraDermics Inc. – Investigator(Grants/Research Funding); Vial – Investigator(No Compensation Received); Vydence Medical – Other(Equipment), Speaker(Honoraria); WeThrivv – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Stock Options);